✦ LIBER ✦

Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism

✍ Scribed by Coleman, Craig I.; Limone, Brendan L.; Bookhart, Brahim K.; Mody, Samir H.; Nutescu, Edith A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of rivaroxaban versus

✍ Seaman, Craig D.; Smith, Kenneth J.; Ragni, Margaret V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 415 KB

PCV22 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ Lukac, M; Bielik, J; Lees, M; Foltan, V; Tomek, D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCV86 COST-UTILITY ANALYSIS OF RIVAROXAB

✍ R Pereira; A Diamantopoulos; J Bielik; M Lees; D Tomek; M Lukac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV26 COST-EFFECTIVENESS OF EXTENDING PR

✍ BA van HOUT; MC Minjoulat-Rey; D Quinlan; A Theeuwes; S Gabriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB